How do you land a Market Access or HEOR role in DACH pharma?
Market Access is one of the most strategically important and best-paid functions in pharma, and in DACH it is unusually specialised because of the AMNOG system. Roles are won by candidates whose CV proves real pricing, reimbursement or evidence experience, whose profile the ATS can parse, and who reach the companies and consultancies hiring, including those that never advertise. I help you on all three fronts, from the recruiting side.
What Market Access does, and who is hiring in DACH
Market Access secures a price and reimbursement for a medicine and defends its value to payers. The function spans pricing and reimbursement strategy, health-technology assessment submissions, value dossiers, health-economic and outcomes research (HEOR), real-world evidence and payer engagement. It sits at the commercial-scientific intersection and increasingly decides whether a launch succeeds.
In DACH the employers are innovator sponsors such as Bayer, Roche, Boehringer Ingelheim and Novartis, biotech companies with launch assets, and specialist Market Access and HEOR consultancies. What makes the region distinctive is Germany's AMNOG process, with early-benefit assessment by the G-BA and IQWiG, alongside the Swiss and Austrian systems. Employers reward candidates who genuinely understand these national mechanisms.
What recruiters and the ATS look for in a Market Access CV
When access CVs crossed my desk, the strong ones were specific about submissions and outcomes. They named the systems worked in, the dossiers delivered, the therapeutic areas, and the payer results, not just a list of responsibilities. A CV that only says "responsible for market access" gives a screening system nothing to rank.
A credible Market Access CV surfaces pricing and reimbursement, health-technology assessment, AMNOG and G-BA/IQWiG dossiers, value and evidence generation, health-economic modelling, real-world evidence, payer engagement and cross-functional launch work. For HEOR specifically, modelling, systematic review and outcomes research come to the front. Naming the systems and submissions you have delivered moves you up a shortlist.
The DACH-specific reality
Two things shape access searches here. National-system knowledge is the first and biggest: AMNOG expertise is genuinely valued and hard to fake, so how you present your German HTA experience matters a great deal. The second is the split between in-house access roles and consultancy, which changes the variety of assets, the pace and the progression. German is frequently important given the payer landscape. Positioning around the right system and setting focuses the search.
How I help Market Access professionals
I recruited commercial and scientific talent inside pharma, so I know how these applications are read and how these hires are made. For Market Access professionals that means a CV and LinkedIn rewrite tuned to the access, HTA and evidence terms recruiters search for, reverse recruitment into unadvertised Market Access and HEOR roles, focused interview preparation for access and competency questions, and honest salary-negotiation coaching when the offer arrives.
Frequently asked questions
What qualifications do you need for a Market Access or HEOR role?
Market Access and HEOR roles usually ask for a background in health economics, pharmacy, epidemiology, life sciences or a related field, and often a postgraduate degree for HEOR. Employers hire on demonstrable experience with pricing and reimbursement, value dossiers, health-technology assessment and payer engagement.
What does the Market Access career path look like?
A common path runs from Analyst and Manager to Senior Manager and Head of Market Access, with specialisms in pricing and reimbursement, HEOR, value and evidence, and public affairs. Progression turns on ownership of submissions, payer negotiations and cross-functional launch work.
Why is Market Access especially important in the DACH region?
Germany runs one of the most consequential value-assessment systems in Europe through AMNOG and the early-benefit assessment by the G-BA and IQWiG, and Switzerland and Austria have their own demanding processes. That makes DACH Market Access highly specialised and well paid.
Which skills should a Market Access or HEOR CV highlight?
Strong CVs surface pricing and reimbursement, health-technology assessment, AMNOG and G-BA/IQWiG dossiers, value and evidence generation, health-economic modelling, real-world evidence and payer engagement. For HEOR, modelling, systematic review and outcomes research come to the front.
How do I move into Market Access from a clinical, commercial or health-economics background?
The move is common from adjacent functions, but it rarely works by applying cold. It works when your evidence, commercial or clinical experience is translated into access and value language, your CV passes the ATS, and you are put in front of the companies and consultancies hiring in this space.
Can you find Market Access and HEOR roles that are not advertised?
Yes. Through reverse recruitment I search for Market Access and HEOR roles, tailor your application and approach hiring managers directly, including positions that never reach the public job boards.